Retatrutide GLP-1 Isn't Approved. MILLIONS Are Already Using It RIGHT NOW.
Description: Retatrutide could become the most powerful weight-loss drug yet, and it may push obesity treatment into completely new territory. Unlike Ozempic and Wegovy, which primarily target GLP-1, Retatrutide activates three hormone pathways at once: GLP-1, GIP, and glucagon. That combination is what makes it different.
GLP-1 suppresses appetite. GIP helps regulate how the body processes incoming energy. And glucagon may push the body toward releasing stored fuel rather than simply consuming less of it. The results have attracted enormous attention.
Clinical trials have reported average weight loss approaching 30% of total body weight at the highest doses-levels that begin to resemble outcomes traditionally associated with bariatric surgery. But Retatrutide is still investigational.
Researchers are continuing to study its long-term safety, including effects on heart rate, muscle loss, and neurological symptoms such as dysesthesia.
Meanwhile, unapproved versions are already being sold online, despite having no legitimate quality control or guarantee that the vial contains what the label claims. That creates two very different stories.
Inside controlled clinical trials, Retatrutide could represent a major advance in metabolic medicine. Outside them, it becomes an uncontrolled experiment.
So is Retatrutide really the “King Kong” of weight-loss drugs? The early data is extraordinary, but the safety story is still being written.
01:37 - How Ozempic Changed the Science of Obesity
05:16 - Why Retatrutide Targets Three Hormones at Once
08:01 - How Retatrutide Forces the Body to Burn Fat
13:27 - The Gila Monster Discovery Behind GLP-1 Drugs
17:22 - The Billion-Dollar Race Between Novo Nordisk and Eli Lilly
18:33 - The Clinical Trials That Put Retatrutide Ahead
21:29 - Heart Risks, Muscle Loss and New Side Effects
23:59 - The Dangerous Gray Market for Unapproved Retatrutide
Narrated by: Josh Risser
🔔 Don't forget to SUBSCRIBE! 🔔
SUGGEST A TOPIC: https://bit.ly/suggest-an-infographics-video
💬 Come chat with me: https://discord.gg/theinfoshow
🔖 MY SOCIAL PAGES
TikTok ► https://www.tiktok.com/@theinfographicsshow
Facebook ► https://www.facebook.com/TheInfographicsShow
📝 SOURCES: https://pastebin.com/ZhXW51Wd
All videos are based on publicly available information unless otherwise noted. Close description
GLP-1 suppresses appetite. GIP helps regulate how the body processes incoming energy. And glucagon may push the body toward releasing stored fuel rather than simply consuming less of it. The results have attracted enormous attention.
Clinical trials have reported average weight loss approaching 30% of total body weight at the highest doses-levels that begin to resemble outcomes traditionally associated with bariatric surgery. But Retatrutide is still investigational.
Researchers are continuing to study its long-term safety, including effects on heart rate, muscle loss, and neurological symptoms such as dysesthesia.
Meanwhile, unapproved versions are already being sold online, despite having no legitimate quality control or guarantee that the vial contains what the label claims. That creates two very different stories.
Inside controlled clinical trials, Retatrutide could represent a major advance in metabolic medicine. Outside them, it becomes an uncontrolled experiment.
So is Retatrutide really the “King Kong” of weight-loss drugs? The early data is extraordinary, but the safety story is still being written.
01:37 - How Ozempic Changed the Science of Obesity
05:16 - Why Retatrutide Targets Three Hormones at Once
08:01 - How Retatrutide Forces the Body to Burn Fat
13:27 - The Gila Monster Discovery Behind GLP-1 Drugs
17:22 - The Billion-Dollar Race Between Novo Nordisk and Eli Lilly
18:33 - The Clinical Trials That Put Retatrutide Ahead
21:29 - Heart Risks, Muscle Loss and New Side Effects
23:59 - The Dangerous Gray Market for Unapproved Retatrutide
Narrated by: Josh Risser
🔔 Don't forget to SUBSCRIBE! 🔔
SUGGEST A TOPIC: https://bit.ly/suggest-an-infographics-video
💬 Come chat with me: https://discord.gg/theinfoshow
🔖 MY SOCIAL PAGES
TikTok ► https://www.tiktok.com/@theinfographicsshow
Facebook ► https://www.facebook.com/TheInfographicsShow
📝 SOURCES: https://pastebin.com/ZhXW51Wd
All videos are based on publicly available information unless otherwise noted. Close description
